EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Impact of Heart Failure Hospitalizations on Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair: Results from the EXPAND Study

Mirjam Kessler, Wolfgang Rottbauer, Ralph Stephan von Bardeleben, Carmelo Grasso, Philipp Lurz, Paul Mahoney, Matthew Price, Mathew Williams, Paolo Denti, Rodrigo Estevez-Loureiro, Saibal Kar, Francesco Maisano

European Journal of Heart Failure · 2024

DOI: 10.1002/ejhf.3250 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Heart Failure, 2024. Verfasst von Mirjam Kessler und 11 weiteren Autor:innen. Beteiligte Einrichtung: Ulm University Heart Center, University of Ulm, Ulm, Germany. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Heart Failure, Cardiac Catheterization, Hospitalization. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The EXPAND study was funded and sponsored by Abbott Structural Heart, Abbott Structural Heart.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

This analysis aimed to compare the clinical outcomes associated with heart failure (HF) readmissions and to identify associations with HF hospitalizations (HFH) in patients treated with the MitraClip™ NTR/XTR System in the EXPAND study. Methods and results The global, real-world EXPAND study enrolled 1041 patients with primary or secondary mitral regurgitation (MR) treated with the MitraClip NTR/XTR System. Echocardiograms were analysed by an independent echocardiographic core laboratory. The study population was stratified into HFH and No-HFH groups based on the occurrence of HFH 1 year post-index procedure. Clinical outcomes including MR severity, New York Heart Association (NYHA) functional class, Kansas City Cardiomyopathy Questionnaire (KCCQ) score, and all-cause mortality were compared (HFH: n = 181; No-HFH: n = 860). Both groups achieved consistent 1-year MR reduction to ≤1+ (HFH vs. No-HFH: 87.3% vs. 89.5%, p = 0.6) and significant 1-year improvement in KCCQ scores (+16.5 vs. +22.3, p = 0.09) and NYHA functional class. However, more patients in the No-HFH group had 1-year NYHA class ≤II (HFH vs. No-HFH: 67.9% vs. 81.9%, p < 0.01). All-cause mortality at 1 year was 36.8% in the HFH group versus 10.4% in the No-HFH group (p < 0.001). The HFH rate decreased by 63% at 1 year post-M-TEER versus 1 year pre-treatment (relative risk 0.4, p < 0.001). Independent HFH associations were MR ≥2+ at discharge, HFH 1 year prior to treatment, baseline NYHA class ≥III, baseline tricuspid regurgitation ≥2+, and baseline left ventricular ejection fraction ≤40%.

Conclusions

This study reports the impact of HFH on clinical outcomes post-treatment in the EXPAND study. Results demonstrate that the occurrence of HFH was associated with worse 1-year survival, and treatment with the MitraClip system substantially reduced HFH and improved patient symptoms and quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyHeart FailureCardiac CatheterizationHospitalizationHumansMaleFemaleAgedAged, 80 and overTreatment OutcomeEchocardiographyMitral ValveHeart Valve Prosthesis ImplantationSeverity of Illness IndexFollow-Up Studies

Stichwörter der Autor:innen

Heart failure hospitalizationMitral regurgitationMitral valve repairTranscatheter edge‐to‐edge repair

Autor:innen und Institutionen

  • Ulm University Heart Center, University of Ulm, Ulm, Germany.
  • University Medical Center of Johannes Gutenberg University, Mainz, Germany.
  • Ferrarotto Hospital, University of Catania, Catania, Italy.
  • Heart Center Leipzig - University Hospital, Leipzig, Germany.
  • Scripps Clinic, La Jolla, CA, USA.
  • Heart Valve Center, New York University Langone Health, New York, NY, USA.

Förderung

  • The EXPAND study was funded and sponsored by Abbott Structural Heart
  • Abbott Structural Heart

Zitieren

APA

Kessler, M., Rottbauer, W., von Bardeleben, R. S., Grasso, C., Lurz, P., Mahoney, P., Price, M., Williams, M., Denti, P., Estevez-Loureiro, R., Kar, S., & Maisano, F. (2024). Impact of Heart Failure Hospitalizations on Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair: Results from the EXPAND Study. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.3250

Vancouver

Kessler M, Rottbauer W, von Bardeleben RS, Grasso C, Lurz P, Mahoney P, et al. Impact of Heart Failure Hospitalizations on Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair: Results from the EXPAND Study. European Journal of Heart Failure. 2024. doi:10.1002/ejhf.3250

BibTeX
@article{Kessler2024,
  author = {Kessler, Mirjam and Rottbauer, Wolfgang and von Bardeleben, Ralph Stephan and Grasso, Carmelo and Lurz, Philipp and Mahoney, Paul and Price, Matthew and Williams, Mathew and Denti, Paolo and Estevez-Loureiro, Rodrigo and Kar, Saibal and Maisano, Francesco},
  title = {Impact of Heart Failure Hospitalizations on Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair: Results from the EXPAND Study},
  journal = {European Journal of Heart Failure},
  year = {2024},
  doi = {10.1002/ejhf.3250}
}
Kostenlos starten →